Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

A health professional vaccinating a person

New rabies vaccine could provide protection for adults and children with a single dose

A new clinical trial led by researchers at the Jenner Institute in collaboration Ifakara Health Institute Tanzania, suggests that a single-dose rabies vaccine could provide safe, long-lasting protection in both adults and children. The research could lead to a simpler, lower-cost approach that could transform rabies prevention in high-risk regions.

Illustration of a man providing comfort to a woman who is crying

New model of care could prevent more than 10,000 miscarriages a year in the UK, Tommy’s report suggests

A new study by Tommy’s researchers, led by Professor Arri Coomarasamy, from the Nuffield Department of Women’s & Reproductive Health, suggests that offering follow-up care from the first miscarriage could help prevent around 10,000 pregnancy losses each year in the UK.

Enzyme responsible for producing itaconate

Research uncovers new mechanism controlling inflammation in immune cells

Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.

Samira Lakhal-Littleton

Professor Samira Lakhal-Littleton and collaborators awarded 15 million euros to advance research into heart failure

Professor Samira Lakhal-Littleton from the Department of Physiology, Anatomy and Genetics is part of a team of international collaborators awarded 15 million euros, including 2.6 million euros to Oxford, from the European Research Council.

A hand writing on top of a medicine jar

Antiretroviral therapy blocks rapid HIV-driven evolution of humans Oxford-led study finds

A new study led by researchers at the University of Oxford demonstrates that the huge success of effective antiretroviral therapy (ART) against HIV could have altered the course of human evolution.

Two heart shapes and a stethoscope

Associate Professor Daniel McGowan from the Department of Oncology joins €50m European study on heart health in cancer patients

Researchers from the Department of Oncology are part of a €50 million European project looking at how innovative medical and digital technologies can improve the early detection of heart-related problems in cancer patients and survivors.

Study reveals lifetime obesity exposure in cancer patients is widely underestimated

New data published today in the European Society for Medical Oncology (ESMO) Real World Data and Digital Oncology show that more than half of people receiving systemic anticancer treatment had a history of obesity, compared with only around one in four who were classified as obese at the time their treatment began.

A mosquito bites a finger.

University of Oxford and Serum Institute of India agree licence to advance the next-generation multi-stage malaria vaccine candidate component

The University of Oxford, through Oxford University Innovation (OUI), and the Serum Institute of India (SII), a Cyrus Poonawalla group company and the world’s largest vaccine manufacturer by volume, have entered into a licence agreement to support the development and manufacture of the new malaria vaccine candidate R78C, based on two Plasmodium falciparum blood-stage antigens (RIPR and CyPRA), for use in clinical settings.

Participant undergoing TUS while carrying out a reaction-time test. Credit: John Eraifej.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford University researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.

A doctor and a young girl in Africa

Expert comment: World Malaria Day 2026 - Malaria vs the data collective

Malaria is one of the world’s oldest known diseases, but it is a modern disease too - it continues to kill roughly 600,000 people each year. Most of these people are children, living in Sub-Saharan Africa.

A female doctor and a patient

Blood pressure lowering reduces cardiovascular risk across all stages of chronic kidney disease

A major international study led by researchers at the Nuffield Dept of Women's & Reproductive Health, University of Oxford has found that lowering blood pressure reduces the risk of cardiovascular disease by approximately 9–10% for every 5 mm Hg reduction in systolic blood pressure with consistent benefits across all stages of chronic kidney disease (CKD).

a clinician and patient in conversation about a treatment decision in primary care.

COVID antiviral speeds recovery but doesn't reduce hospitalisation in vaccinated patients, trials find

The PANORAMIC trial, led from Oxford's Nuffield Department of Primary Care Health Sciences, finds that Paxlovid speeds COVID-19 recovery but does not reduce hospitalisations or deaths in vaccinated higher-risk adults. Published alongside Canada's CanTreatCOVID trial in the New England Journal of Medicine.

Operating Room of Surgical Table with Instruments, Assistant Picks up Instruments for Surgeons During Operation. Surgery in Progress. Professional Medical Doctors Performing Surgery.

Hiring alone won't clear NHS surgery backlogs without tackling staff strain, study finds

Despite the NHS adding roughly 250,000 staff between 2018 and 2023, elective surgery waiting lists kept growing. New research analysing 132 NHS Trusts finds that staff sickness absence and unstable administrative teams – not workforce size – are key factors.

Bunk beds

New data links 104 child deaths in England to temporary accommodation

New data reveals that 104 children in England have died between April 2019 and 3 December 2024 with temporary accommodation identified as a contributing factor to their vulnerability, ill health or death.

photo of a women holding a model red heart

Oxford researchers awarded International Cardiovascular Research Partnership Award to advance cardiovascular disease research

Associate Professor Lisa Heather, from the Department of Physiology, Anatomy and Genetics (DPAG), has been awarded an International Cardiovascular Research Partnership Award (ICRPA). The ICRPA scheme supports high-quality international research collaborations that have the potential to accelerate progress towards improved understanding, prevention, diagnosis and treatment of cardiovascular disease.

Professor Asifa Majid

Professor Asifa Majid awarded Humboldt Research

Professor Asifa Majid of the Department of Experimental Psychology has been awarded the prestigious Humboldt Research Award by the Alexander von Humboldt Foundation.

Professor Michele Hu, Dr Elisha Ward, Clare Mackay, Dr Irmak Yazici and other speakers and participants at the event,

Women in Clinical Neurosciences (WICN) mark International Women's Day 2026

To mark 2026 International Women’s Day, the NDCN Women in Clinical Neurosciences (WICN) committee organised a series of informative and inspiring talks on 6 March, with the focus on empowering career progression for all at the Nuffield Department of Clinical Neurosciences (NDCN).

A young girl dressed with a cape and with a white bandage on her left arm

Large UK trial shows bone healing ‘superpower’ in children

Most children with a severely broken wrist can be treated without surgery, according to a major NIHR-funded UK trial led by researchers at the University of Oxford. The findings suggest that a non-surgical, cast-first approach delivers similar long-term recovery while reducing the risks associated with surgery and costs.

Photo of a hospital ward. Image is focus on pinned paper written 'Recovery Trial'.

RECOVERY trial hailed as one of the two success stories of the COVID-19 pandemic

The Chair of the COVID-19 Inquiry has described the RECOVERY trial’s identification of the drug dexamethasone as ‘one of the two success stories of the pandemic’.

Petersson group

New funding to fast-track ultra-fast FLASH radiotherapy into the clinic

A new EPSRC-funded research project led by Dr Kristoffer Petersson from the Department of Oncology aims to advance the clinical implementation of FLASH radiotherapy, an emerging technique that delivers radiation in a fraction of a second and may significantly reduce treatment side effects.

Load More